Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0. It has been cited 45 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: R37AI054193
FP7 Ideas: European Research Council
Grant: ERC-STG INTRACELLTB n° 260901, MM4TB n°260872
NIH
Grant: HHSN272201100009I
Agence Nationale de la Recherche
Grant: ANR-10-EQPX-04-01, ANR-14-CE08-0017, ANR-16-CE35-0009),
Région Nord Pas de Calais
Grant: n°12000080
European Research Council
Grant: 260872
European Research Council
Grant: 260901
NIGMS NIH HHS
Grant: P20 GM103474
NIAID NIH HHS
Grant: HHSN272201100009C
FWCI
0.70
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals